Analysts Rating: Stoke Therapeutics Inc (NASDAQ:STOK) Stock Won “an Outperform” Rating From TD Cowen
TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]
A positive surprise is on the way: Stoke Therapeutics Inc (STOK) Stock
TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]
Opportunities: Stoke Therapeutics Inc (STOK) Stock in the Short-Term and the Long-Term
TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]
Stoke Therapeutics Inc (NASDAQ:STOK) stock Posted Gross Margin of 40.15 percent in Last Year: Is Justifiable?
TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]
With upside potential, Stoke Therapeutics Inc (STOK) Stock is well-positioned to grow
TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]
There is no better tap than Stoke Therapeutics Inc (STOK) Stock
TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]
In the long run, Stoke Therapeutics Inc (STOK) Stock makes the most sense financially and strategically
TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]
Don’t be afraid of Stoke Therapeutics Inc (STOK) Stock despite uncertainty and doubt
TD Cowen raised the price target for the Stoke Therapeutics Inc (NASDAQ:STOK) stock from “a Market perform” to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The stock was upgraded by BofA Securities, who disclosed in a research note on May 01, 2023, from Underperform to Neutral and set the […]
